Regencell Bioscience Holdings (Regencell Bioscience Holdings) 1-Year ROIIC %

: -246.15% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Regencell Bioscience Holdings's 1-Year ROIIC % for the quarter that ended in Jun. 2023 was -246.15%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Regencell Bioscience Holdings's 1-Year ROIIC % or its related term are showing as below:

RGC's 1-Year ROIIC % is ranked worse than
92.54% of 898 companies
in the Drug Manufacturers industry
Industry Median: 1.345 vs RGC: -246.15

Regencell Bioscience Holdings 1-Year ROIIC % Historical Data

The historical data trend for Regencell Bioscience Holdings's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

1-Year ROIIC %

-37.76

-75.07

316.60

-246.15

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
1-Year ROIIC %					-75.07	-22.00	316.60	49.27	-246.15

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings 1-Year ROIIC % Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's 1-Year ROIIC % falls into.

Regencell Bioscience Holdings 1-Year ROIIC % Calculation

Regencell Bioscience Holdings's 1-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

1-Year ROIIC %	=	1-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	1-Year Incremental Invested Capital
	=	( -6.274 (Jun. 2023) - -7.618 (Jun. 2022) )	/	( 1.439 (Jun. 2023) - 1.985 (Jun. 2022) )
	=	1.344	/	-0.546
	=	-246.15%^***

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Regencell Bioscience Holdings (NAS:RGC) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Regencell Bioscience Holdings 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » 1-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.